Journal
BONE MARROW TRANSPLANTATION
Volume 32, Issue -, Pages S29-S31Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.bmt.1704177
Keywords
hematopoietic stem cell; peripheral vascular disease; coronary artery disease
Categories
Ask authors/readers for more resources
Recent studies have suggested that marrow and blood hematopoietic stem cells may contribute to nonhematopoietic tissue repair in multiple organ systems. In animal models and more recently in limited human trials, unpurified marrow mononuclear cells and/or subsets of adult hematopoietic stem cells have been reported to contribute to neoangiogenesis. Since the subset of hematopoietic stem cells (HSCs) that are both CD34(+) and AC 133(+) are endothelial cell precursors, clinical trials using autologous AC133(+) HSCs isolated with the Miltenyi CLIMACS cell separator and transplanted into patients with ischemic and refractory peripheral vascular or coronary artery disease are being implemented at Northwestern University.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available